Invention Grant
- Patent Title: Uses
-
Application No.: US15709258Application Date: 2017-09-19
-
Publication No.: US10398698B2Publication Date: 2019-09-03
- Inventor: Lawrence P. Wennogle , Robert Davis
- Applicant: INTRA-CELLULAR THERAPIES, INC.
- Applicant Address: US NY New York
- Assignee: INTRA-CELLULAR THERAPIES, INC.
- Current Assignee: INTRA-CELLULAR THERAPIES, INC.
- Current Assignee Address: US NY New York
- Agency: Hoxie & Associates LLC
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K45/06
Abstract:
The invention relates to the administration of inhibitors of phosphodiesterase 1 (PDE1) for the treatment of diseases or disorders characterized by disruption of or damage to various cGMP/PKG mediated pathways. In one embodiment the invention relates to inhibitors of phosphodiesterase 1 (PDE1) for treatment of cardiovascular disease and related disorders, e.g., congestive heart disease, atherosclerosis, myocardial infarction, and stroke.
Public/Granted literature
- US20180177782A9 NOVEL USES Public/Granted day:2018-06-28
Information query
IPC分类:
